SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 50,200
-200 (-0.40%)
At close: Feb 11, 2026
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.94 trillion as of February 11, 2026. Its market cap has increased by 2.15% in one year.
Market Cap
3.94T
Enterprise Value
3.58T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
50,200.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.94T, a decrease of -69.54%. That is a compound annual growth rate of -21.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.95T | 4.62% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 8.59T |
| HLB Co., Ltd. | 7.00T |
| LigaChem Biosciences | 6.49T |
| Peptron | 6.21T |
| Voronoi | 3.97T |
| D&D Pharmatech | 3.57T |
| PharmaResearch | 3.50T |
| OliX Pharmaceuticals | 2.71T |